Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15339686 | 0.86 | ALDH1A1 (0.46) | TSHRALDH1A1TDP1LMNAFDPS | |
| SCHEMBL1117374 | 0.84 | LMNA (0.42) | TSHRALDH1A1TDP1LMNAFDPS | |
| SCHEMBL1170692 | 0.84 | LMNA (0.42) | TSHRALDH1A1TDP1LMNAFDPS | |
| SCHEMBL1117343 | 0.80 | LMNA (0.39) | TSHRALDH1A1LMNA | |
| SCHEMBL393469 | 0.77 | — | — | |
| SCHEMBL1117310 | 0.77 | ALDH1A1 (0.38) | ALDH1A1LMNAFDPS | |
| SCHEMBL2099935 | 0.76 | LMNA (0.42) | TSHRALDH1A1TDP1LMNA | |
| SCHEMBL1117694 | 0.75 | ALDH1A1 (0.37) | ALDH1A1LMNAFDPS | |
| SCHEMBL1117469 | 0.75 | ALDH1A1 (0.39) | ALDH1A1LMNAFDPS | |
| SCHEMBL28415354 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4223315-A2 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | Ionis Pharmaceuticals, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-3811977-A1 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | Ionis Pharmaceuticals, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| EP-3137115-B1 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | IONIS PHARMACEUTICALS INC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20170043025-A1 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | IONIS PHARMACEUTICALS, INC. (US) | 2017-02-16 | — | — | US | disclosed |
| US-7772431-B1 | Performance of energy storage devices: potential areas for dendritic chemistry involvement | NEWKOME GEORGE R | 2010-08-10 | — | — | US | disclosed |
| US-7250534-B1 | Performance of energy storage devices: potential areas for dendritic chemistry involvement | UNIVERSITY OF SOUTH FLORIDA (US) | 2007-07-31 | — | — | US | disclosed |
| WO-2001007497-A2 | PERFORMANCE OF ENERGY STORAGE DEVICES: POTENTIAL AREAS FOR DENDRITIC CHEMISTRY INVOLVEMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170043025-A1 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | ACOT7, COASY, LCAT | TSHR 1805/4885ALDH1A1 1477/4885TDP1 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.